| Theme | Apheresis Update | |
|---|---|---|
| Title | Apheresis therapy for cardiovascular disease | |
| Publish Date | 2011/11 | |
| Author | Akiyasu Baba | Kitasato Institute Hospital, Kitasato University |
| [ Summary ] | Low density lipoprotein (LDL) apheresis for peripheral arterial diseases and familial hypercholesterolemia is accepted as a form of additional therapy for standard treatment resistance in cardiovascular disease. In addition, apheresis for cardiac failure has recently been evaluated in terms of its ability to counter autoantibody related conditions encountered in dilated cardiomyopathy. | |